Tower Research Capital LLC (Trc) Theravance Biopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,170 shares of TBPH stock, worth $20,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,170
Previous 5,013
76.66%
Holding current value
$20,346
Previous $55,000
69.09%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding TBPH
# of Institutions
171Shares Held
50.5MCall Options Held
36.5KPut Options Held
147K-
Madison Avenue Partners, LP New York, NY9.51MShares$165 Million12.7% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$130 Million2.09% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$86.1 Million12.08% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$65.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$48 Million4.22% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $1.16B
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...